Antiva Biosciences
Jenny Yip is the current director at Antiva Biosciences. Jenny has also worked as a partner at Bill & Melinda Gates Foundation, vice president in the investment banking division at Goldman Sachs, and board observer at Kymab Ltd.
Yip has a long history of working with companies in the healthcare and bioscience industries. Jenny started their career at Goldman Sachs in the Investment Banking Division, where they worked for 10 years. Jenny then transitioned to the Bill & Melinda Gates Foundation, where they were a Partner for 7 years. In this role, they were responsible for managing the Foundation's $2 billion Strategic Investment Fund.
Yip has also served on the boards of several companies, including Acrobatiq, Owl Ventures, LP, and Reach Capital. Jenny is currently a member of the LPAC and Social Impact Committee at Reach Capital.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Antiva Biosciences
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. They aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV.